Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Praxis Precision Medicines, Inc. Common Stock (PRAX).
- Disclosed ownership: 2.9%.
- Date of event: 30 Sep 2025.
MORGAN STANLEY - 30 Sep 2025 SCHEDULE 13G/A Report for Praxis Precision Medicines, Inc. Common Stock (PRAX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- PRAX
- Shares outstanding
- 21,309,655 shares
- Disclosed Ownership
- 617,980 shares
- Ownership
- 2.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Nov 2025, 13:19:45 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 05 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 2.9% ownership in Praxis Precision Medicines, Inc. Common Stock (PRAX) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 05 Feb 2025.
- Current filing was accepted on 07 Nov 2025, 13:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 2.9% | 617,980 | 0 | 617,206 | Christopher O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 1.4% | 296,731 | 0 | 296,731 | Christopher O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |